Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 May 15;13(5):e0197379.
doi: 10.1371/journal.pone.0197379. eCollection 2018.

Comprehensive evaluation of blood-brain barrier-forming micro-vasculatures: Reference and marker genes with cellular composition

Affiliations

Comprehensive evaluation of blood-brain barrier-forming micro-vasculatures: Reference and marker genes with cellular composition

Mei Dai et al. PLoS One. .

Abstract

Primary brain microvessels (BrMV) maintain the cellular characters and molecular signatures as displayed in vivo, and serve as a vital tool for biomedical research of the blood-brain barrier (BBB) and the development/optimization of brain drug delivery. The variations of relative purities or cellular composition among different BrMV samples may have significant consequences in data interpretation and research outcome, especially for experiments with high-throughput genomics and proteomics technologies. In this study, we aimed to identify suitable reference gene (RG) for accurate normalization of real-time RT-qPCR analysis, and determine the proper marker genes (MG) for relative purity assessment in BrMV samples. Out of five housekeeping genes, β-actin was selected as the most suitable RG that was validated by quantifying mRNA levels of alpha-L-iduronidase in BrMV isolated from mice with one or two expressing alleles. Four marker genes highly/selectively expressed in BBB-forming capillary endothelial cells were evaluated by RT-qPCR for purity assessment, resulting in Cldn5 and Pecam1 as most suitable MGs that were further confirmed by immunofluorescent analysis of cellular components. Plvap proved to be an indicator gene for the presence of fenestrated vessels in BrMV samples. This study may contribute to the building blocks toward overarching research needs on the blood-brain barrier.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. The expression stability of RG candidates among endothelial cell lines and brain samples.
Total RNA was extracted and converted into cDNA by reverse-transcription at 25 ng/ul, and followed by real-time qPCR with 25 ng/reaction. (A) Distribution of cycle threshold (Ct) values for five RG candidates by quantitative RT-PCR in BMEC and bEnd3 cell lines. The experiments were repeated 3 times in duplicate reactions. Boxes showed the range of Ct values for each candidate gene. The central line indicated the median Ct; the extended upper and lower indicate 75 and 25 percentiles. (B) The average expression stability (M value) of RG candidates in two endothelial cell lines analyzed by geNorm. RG candidates were ranked from the least stable to the most stable (left to right). (C) Ct values for four RG candidates in BrMV and CDB. Data were derived from 10 BrMV isolation experiments with 4 from WT mice, 2 from Het and 4 from Idua knock-out mice. Each sample was tested 3 times in duplicate. **, p<0.01, and ***, p<0.001. (D) The expression stability of four reference genes among all BrMV and CDB samples analyzed by geNorm. (E) RG candidates were ranked in the order of their expression stability evaluated by Bestkeeper based on coefficient of variation (CV%) and SD.
Fig 2
Fig 2. Quantification of RNA input using RG standard curves derived from 3T3 or primary CDB samples.
Total RNA samples isolated from 3T3 cell line or CDB samples of C57/Bl6 mice were serially diluted, applied for reverse transcription, and followed by qPCR of 4 reference genes. (A) Standard curves of RNA amounts generated by qPCR of 4 RGs. Data were derived from 3 dilution sets with each amplified in triplicates. E, amplification efficiency for a combination of RT and qPCR steps calculated from the slope of each standard curve; R2 range from 0.986 to 0.998. (B) Quantification of total RNA inputs of BrMV and CDB isolates from 10 isolation experiments using different standard curves. Reverse transcription was conducted at 25 ng/ul (by NanoDrop) for all RNA samples, and real-time qPCR was performed using 25 ng/reaction (and indicated as dashed line). Each symbol represents mean of calculated RNA amount derived from Ct value of triplicate qPCR reactions of one sample. Short lines represent mean ± SD of RNA amounts calculated using different standard curves from each of RGs.
Fig 3
Fig 3. Verification of Actb as the best reference gene by Idua expression in BrMV of WT mice and Het mice.
(A) Standard curve for absolute quantification of Idua mRNA. A plasmid containing Idua cDNA was used for generating standard curve with copy numbers by qPCR. Data was derived from 2 sets of standard samples, each amplified three times in duplicate. Error bars, standard deviation. (B, C) Idua expression in BrMV isolated from either wild-type C57/Bl6 mice (WT) or littermates of heterozygous for Idua knock-out (Het) with normalization by RG candidates. Total RNA from 4 WT and 4 Het samples were examined by RT-qPCR and calculated either by absolute Idua standard curve for copy numbers per ng RNA (B), or by ΔΔCt method for relative Idua fold changes (C).
Fig 4
Fig 4. Choice of marker genes to assess the purity of BrMV samples.
(A) Distribution of threshold cycle (Ct) values for MG candidates in BrMV and CDB samples by RT-qPCR. Each sample is repeated 3 times in duplicate reactions, and each symbol represents the mean of one sample. Short lines represent mean ± SD of Ct values for each marker gene, n = 10. (B) Relative purity curves determined by relative quantitation of mRNA between different marker genes and Actb (as reference gene). One BrMV sample with relatively high marker gene expression over CDB samples was designated as “100%” relative purity and two sets of standard samples were generated by serial dilution of this BrMV with CDB samples (considered as “0%”). Data were derived from 2 sets of standard samples with 3 RT-qPCR experiments in duplicate reactions. The R2 ranges from 0.968 to 0.971.
Fig 5
Fig 5. Cellular components of BrMV isolates determined by immunostaining.
(A) Representative pictures of immunofluorescence analysis for BrMV isolates. The brain BrMV isolates were stained with fluorescein-labeled (green) lectin for BBB-forming endothelial cells, and Alexa 568-conjugated (red) anti-mouse CD68 for brain macrophages, anti-mouse GFAP for astrocytes, anti-mouse NeuN for neurons, or anti-mouse PDGFR-β for pericytes, and followed by counter-staining with DAPI (blue) for nucleic. Scale bar represents 50 μm for all views. (B) Semi-quantifications of cellular composition for nine BrMV samples. Each sample was evaluated with a total of >500 nuclei. Pearson correlation coefficient between Lectin+ and other cell types are -0.862 for CD68+ cells, -0.837 for GFAP+ cells, -0.776 for NeuN+ and -0.190 for PDGFR+ cells. (C) Semi-quantification of main cell types in BrMV isolates. Data are derived from 4 BrMV samples with similar purities (ranging of 64–69%) as determined by immunostaining; error bars represent SD. CV, coefficient of variation.
Fig 6
Fig 6. Correlation of purities measured by both qPCR and immunofluorescent microscopy.
The relative purities of BrMV samples were determined by real-time RT-qPCR with relative comparison of mRNA abundances using standard curves of different marker genes as described in Fig 4, as well as by immunofluorescence analysis as described in Fig 5. Each symbol represents relative purity of individual BrMV sample derived from 3 RT-qPCR experiments in duplicate reactions for qPCR, as well as from evaluation of >200 DAPI+ nuclei from cytospin slides by immunostaining analysis.

Similar articles

Cited by

References

    1. Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV. Establishment and Dysfunction of the Blood-Brain Barrier. Cell. 2015;163(5):1064–78. doi: 10.1016/j.cell.2015.10.067 ; PubMed Central PMCID: PMC4655822. - DOI - PMC - PubMed
    1. Ochocinska MJ, Zlokovic BV, Searson PC, Crowder AT, Kraig RP, Ljubimova JY, et al. NIH workshop report on the trans-agency blood-brain interface workshop 2016: exploring key challenges and opportunities associated with the blood, brain and their interface. Fluids and barriers of the CNS. 2017;14(1):12 doi: 10.1186/s12987-017-0061-6 ; PubMed Central PMCID: PMC5410699. - DOI - PMC - PubMed
    1. Pan D. Cell- and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses. Curr Pharm Biotechnol. 2011;12(6):884–96. doi: 1389-2010/11$58.00+.00. ; PubMed Central PMCID: PMCPMC4040261. - PMC - PubMed
    1. Montagne A, Zhao Z, Zlokovic BV. Alzheimer's disease: A matter of blood-brain barrier dysfunction? J Exp Med. 2017;214(11):3151–69. doi: 10.1084/jem.20171406 ; PubMed Central PMCID: PMCPMC5679168. - DOI - PMC - PubMed
    1. Salvalaio M, Rigon L, Belletti D, D'Avanzo F, Pederzoli F, Ruozi B, et al. Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders. PloS one. 2016;11(5):e0156452 doi: 10.1371/journal.pone.0156452 ; PubMed Central PMCID: PMCPMC4881964. - DOI - PMC - PubMed

Publication types

LinkOut - more resources